EP3672571B1 - Pharmaceutical Aqueous Formulation Comprising 1-(4-{[4-(dimethylamino)piperidin-1-Yl]carbonyl}phenyl)-3-[4-(4,6-Dimorpholin-4-Yl-1,3,5-Triazin-2-Yl)phenyl]urea